- Home
- FWONA vs DGX Comparison
FWONA vs DGX Comparison
Compare FWONA & DGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FWONA | DGX |
|---|---|---|
| Founded | 1950 | 1967 |
| Country | United States | United States |
| Employees | 1674 | N/A |
| Industry | Broadcasting | Medical Specialities |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.0B | 23.2B |
| IPO Year | N/A | 1996 |
Fundamental Metrics
Financial Performance| Metric | FWONA | DGX |
|---|---|---|
| Price | $88.23 | $227.07 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 13 |
| Target Price | $101.75 | ★ $214.38 |
| AVG Volume (30 Days) | 152.6K | ★ 928.9K |
| Earning Date | 05-07-2026 | 04-21-2026 |
| Dividend Yield | N/A | ★ 1.82% |
| EPS Growth | N/A | ★ 13.78 |
| EPS | N/A | ★ 2.24 |
| Revenue | N/A | ★ $11,035,000,000.00 |
| Revenue This Year | $24.56 | $7.53 |
| Revenue Next Year | $5.52 | $3.77 |
| P/E Ratio | ★ $97.75 | $101.73 |
| Revenue Growth | N/A | ★ 11.78 |
| 52 Week Low | $73.70 | $165.78 |
| 52 Week High | $99.49 | $237.78 |
Technical Indicators
Market Signals| Indicator | FWONA | DGX |
|---|---|---|
| Relative Strength Index (RSI) | 53.02 | 69.99 |
| Support Level | $86.57 | $186.40 |
| Resistance Level | $91.04 | N/A |
| Average True Range (ATR) | 2.17 | 5.18 |
| MACD | -0.35 | 0.62 |
| Stochastic Oscillator | 30.27 | 86.79 |
Price Performance
Historical ComparisonAbout FWONA Liberty Media Corporation Series A Liberty Formula One
Liberty Media Corp along with its subsidiaries is engaged in the media and entertainment industries in North America and the United Kingdom. The company owns interests in a high-quality portfolio of assets across the media, entertainment and sports industries. It operates in two reportable segment Formula 1 and MotoGP. It generates majority of its revenue from the Formula 1 segment. The company derives its maximum revenue from United Kingdom.
About DGX Quest Diagnostics Incorporated
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 97% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,400 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.